Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05713370 · ClinicalTrials.gov registry record · NA

Sleep Restriction and Postprandial Lipemia

A NA study of Obesity and Sleep Deprivation, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT05713370: Completed NA study of Obesity and Sleep Deprivation, sponsored by University of Missouri-Columbia.

NCT05713370 is a NA study of Obesity and Sleep Deprivation that has completed, run by University of Missouri-Columbia. The registered enrollment target is 10 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05713370, a NA study of Obesity and Sleep Deprivation, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

Sleep restriction increases overnight and early morning non-esterified fatty acids (NEFA) levels, which are correlated with whole-body decreases in insulin sensitivity, consistent with the observed impairment of intracellular insulin signaling. Adipose tissue biopsies from sleep restricted subjects that are insulin stimulated have reduced phosphorylation of protein kinase B (pAKT). This protein is involved in suppression of intracellular lipolysis and NEFA release. Aerobic exercise has beneficial effects on postprandial lipemia and insulinemia in normal-weight and obese individuals. Acute moderate-intensity aerobic exercise (30-90 min) performed 12-18 h before an oral fat tolerance test or mixed meal test reduces postprandial triglycerides (TG) and insulin concentrations. This response is largely dependent upon the exercise-induced energy deficit as the response is abolished when the calories expended during exercise are replaced. However, it is not known if sleep restriction will interfere with the beneficial effects of prior exercise on postprandial lipemia. The aim of this project is to investigate if sleep restriction negates the positive effect that exercise has on postprandial lipemia. It is hypothesized that sleep restriction will negate the beneficial effects of prior exercise on postprandial lipemia. Additionally sleep restriction will result in a worsening of the lipid profile compared to no exercise. For the proposed study, the investigators will use a repeated measures analysis of variance (ANOVA) (4 study conditions (no exercise+ sleep restriction, no exercise+normal sleep, exercise+normal sleep, exercise+sleep restriction) x time will be used to analyze changes in NEFA and TG concentrations while a one way ANOVA will be used to analyze area under the curve of the NEFA and TG concentrations.

Primary Outcome

blood samples for free fatty acid concentrations will be taken every 30 minutes for 4 hours

Interventions

  • DIETARY_SUPPLEMENT high fat meal

Study Locations (2)

Missouri

  • University of Misouri - Columbia
  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-07-01
Est. Completion 2023-12-01
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT05713370 record still lists

NCT05713370 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which high fat meal is the first listed.

NCT05713370 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05713370 about?

NCT05713370 is a clinical study titled "Sleep Restriction and Postprandial Lipemia". Sleep restriction increases overnight and early morning non-esterified fatty acids (NEFA) levels, which are correlated with whole-body decreases in insulin sensitivity, consistent with the observed impairment of intracellular insulin signaling. Adipose tissue biopsies from sleep restricted subjects ...

What is the current status of trial NCT05713370?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-07-01. Estimated completion is 2023-12-01.

What conditions does trial NCT05713370 study?

This clinical trial studies the following conditions: Obesity, Sleep Deprivation.

What interventions are being tested in trial NCT05713370?

The interventions under investigation include: high fat meal (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05713370?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05713370 being conducted?

This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05713370's enrollment target sits among peer trials

10 1025th of 1053 higher than 19 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05713370, the US trial registry maintained by the National Library of Medicine. NCT05713370 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.